Australia markets closed

10x Genomics, Inc. (TXG)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
20.25+0.53 (+2.69%)
At close: 04:00PM EDT
20.23 -0.02 (-0.10%)
After hours: 07:22PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close19.72
Open19.61
Bid20.22 x 500
Ask20.28 x 1000
Day's range19.34 - 20.30
52-week range19.34 - 63.57
Volume1,227,643
Avg. volume1,586,361
Market cap2.424B
Beta (5Y monthly)1.87
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • PR Newswire

    10x Genomics Launches 5,000-Plex Gene Panel for Xenium

    10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the launch of its Xenium Prime 5K Pan-Tissue and Pathways panel. The new assay features an enhanced chemistry to increase plex by an order of magnitude while delivering excellent per-gene sensitivity, improved specificity and spatial fidelity, integrated multimodal cell segmentation, and industry-leading speed and throughput.

  • PR Newswire

    10x Genomics to Present at the BofA Securities 2024 Healthcare Conference

    10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that members of its management team will participate in a fireside chat at the BofA Securities 2024 Healthcare Conference on Tuesday, May 14, at 4:20 p.m. Pacific Time.

  • PR Newswire

    10x Genomics Reports First Quarter 2024 Financial Results

    10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the first quarter ended March 31, 2024.